Join
Live feed
·
INSIDERFilingvia Quantisnow
Traws Pharma Inc. logo

Large owner Orbimed Advisors Llc bought $998,207 worth of shares (597,729 units at $1.67) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRAW (Traws Pharma Inc.) and more on Quantisnow.